What is Eli Lilly and Company (LLY.TO)?

Eli Lilly and Company (LLY.TO) is a stock in the Healthcare sector, Drug Manufacturers - General industry. View full analysis on Stocks360.

Eli Lilly and Company (LLY.TO)

Stock analysis · TSX · Healthcare · Drug Manufacturers - General

Market Cap

N/A

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

1.19

Day Range

N/A

52-wk Range

N/A

Avg Volume

N/A

Volume

N/A

Eli Lilly and Company (LLY.TO) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About Eli Lilly and Company

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.